Cargando…

Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis

Levosimendan and dobutamine are extensively used to treat sepsis-associated cardiovascular failure in ICU. Nevertheless, the role and mechanism of levosimendan in patients with sepsis-induced cardiomyopathy remains unclear. Moreover, previous studies on whether levosimendan is superior to dobutamine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dong-Hua, Ning, Yi-Le, Lei, Yan-Yan, Chen, Jing, Liu, Yan-Yan, Lin, Xin-Feng, Yang, Zhong-Qi, Xian, Shao-Xiang, Chen, Wei-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514594/ https://www.ncbi.nlm.nih.gov/pubmed/34645892 http://dx.doi.org/10.1038/s41598-021-99716-9

Ejemplares similares

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Comparison of dobutamine and levosimendan for treatment of sepsis-induced cardiac dysfunction: A protocol for systematic review and meta-analysis
por: Guo, Jun, et al.
Publicado: (2022)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
por: Kandemir, Ulku, et al.
Publicado: (2013)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial
por: Meng, Jian-biao, et al.
Publicado: (2016)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study
por: Kandasamy, Ashok, et al.
Publicado: (2017)

Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery: a randomized noninferiority trial
por: Franco, Rafael Alves, et al.
Publicado: (2021)

Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
por: Guerrero-Orriach, Jose L., et al.
Publicado: (2020)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Time to re-think the use of dobutamine in sepsis
por: Sato, Ryota, et al.
Publicado: (2017)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

Levosimendan protects from sepsis-inducing cardiac dysfunction by suppressing inflammation, oxidative stress and regulating cardiac mitophagy via the PINK-1-Parkin pathway in mice
por: Shi, Jian, et al.
Publicado: (2022)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Untargeted metabolomic profiling of sepsis-induced cardiac dysfunction
por: Cao, Yan, et al.
Publicado: (2023)

Effect of levosimendan on prognosis in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials
por: Chen, Qi-Hong, et al.
Publicado: (2017)

The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression
por: Gao, Yu-Lei, et al.
Publicado: (2017)

Rutin Inhibits Cardiac Apoptosis and Prevents Sepsis-Induced Cardiomyopathy
por: Meng, Xiang-Long, et al.
Publicado: (2022)

The effect of dobutamine in sepsis: a propensity score matched analysis
por: Zhu, Youfeng, et al.
Publicado: (2021)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial
por: Lannemyr, Lukas, et al.
Publicado: (2018)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial
por: Orme, Robert M L’E, et al.
Publicado: (2014)

Comparing the effects of dopexamine and dobutamine on splanchnic parameters in patients with severe sepsis
por: Esen, F, et al.
Publicado: (1998)

Acute haemodynamic effects of dobutamine in experimental sepsis-induced myocardial depression
por: Andreis, DT, et al.
Publicado: (2015)

Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy
por: Ning, Yi-Le, et al.
Publicado: (2020)

Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
por: Yang, Fei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_heeg31vkap0306g97db3ldjmml